MK-4082

DRUG2 trials

Sponsors

Merck Sharp & Dohme LLC

Conditions

Healthy

Phase 1

A Clinical Study of MK-4082 in Healthy Overweight Participants (MK-4082-002)

Active, not recruitingNCT07388667

Merck Sharp & Dohme LLCHealthy

Start: 2026-03-04End: 2026-09-09Target: 120Updated: 2026-06-16

A Clinical Trial of MK-4082 in Healthy Participants (MK-4082-005)

RecruitingNCT07697625

Merck Sharp & Dohme LLCHealthy

Start: 2026-07-20End: 2026-09-28Target: 28Updated: 2026-08-05